MCART1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.326200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.781200E-01
Normal-vs-Stage2
4.263200E-01
Normal-vs-Stage3
4.880400E-02
Normal-vs-Stage4
2.485400E-01
Stage1-vs-Stage2
7.625600E-01
Stage1-vs-Stage3
7.421800E-02
Stage1-vs-Stage4
6.950000E-01
Stage2-vs-Stage3
1.559050E-01
Stage2-vs-Stage4
9.575400E-01
Stage3-vs-Stage4
1.907420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.255000E-01
Normal-vs-AfricanAmerican
8.979200E-01
Normal-vs-Asian
2.542800E-01
Caucasian-vs-AfricanAmerican
4.925400E-01
Caucasian-vs-Asian
2.447600E-01
AfricanAmerican-vs-Asian
2.288400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.225200E-01
Normal-vs-Female
5.621400E-01
Male-vs-Female
7.601600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.905600E-01
Normal-vs-Age(41-60Yrs)
8.590200E-01
Normal-vs-Age(61-80Yrs)
4.222600E-01
Normal-vs-Age(81-100Yrs)
2.488800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.455400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.105800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.713000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.654200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.060020E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.376400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.374160E-01
Normal-vs-Daily Drinker
2.313600E-01
Normal-vs-Weekly Drinker
6.219200E-01
Normal-vs-Occasional Drinker
7.359400E-01
Normal-vs-Social Drinker
5.768400E-01
Non Drinker-vs-Daily Drinker
9.085000E-01
Non Drinker-vs-Weekly Drinker
1.254630E-01
Non Drinker-vs-Occasional Drinker
9.986000E-02
Non Drinker-vs-Social Drinker
6.162800E-03
Daily Drinker-vs-Weekly Drinker
2.216200E-01
Daily Drinker-vs-Occasional Drinker
1.835590E-01
Daily Drinker-vs-Social Drinker
4.599400E-03
Weekly Drinker-vs-Occasional Drinker
8.999000E-01
Weekly Drinker-vs-Social Drinker
1.012830E-01
Occasional Drinker-vs-Social Drinker
1.234350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.464800E-01
Normal-vs-Grade 2
8.324400E-01
Normal-vs-Grade 3
8.696200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.848200E-01
Grade 1-vs-Grade 3
3.042400E-01
Grade 1-vs-Grade 4
5.464800E-01
Grade 2-vs-Grade 3
5.236000E-01
Grade 2-vs-Grade 4
8.324400E-01
Grade 3-vs-Grade 4
8.696200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.895600E-01
Normal-vs-NonDiabetic
5.712800E-01
Diabetic-vs-NonDiabetic
4.669600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.700300E-02
Normal-vs-NoPancreatitis
6.001600E-01
Pancreatitis-vs-NoPancreatitis
4.155800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.131600E-01
Normal-vs-N1
4.725200E-01
N0-vs-N1
8.780400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.615200E-01
Normal-vs-TP53-NonMutant
8.910000E-01
TP53-Mutant-vs-TP53-NonMutant
5.275400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
